Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections

Award Number: R01AI176333
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/23/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections - ABSTRACT Type I interferons (IFN) and IFN stimulated genes (ISGs) provide broad antiviral activities. However, the host protection provided by the IFN and ISGs during bacterial infections is not well defined. This proposal will define new innate immune functions of Oligoadenylate Synthetase (OAS) proteins against intracellular bacterial infections. OASs are a family of ISG that belongs to an evolutionarily ancient family of nucleotidyl-transferases (NTase). The canonical antiviral mechanism of OAS proteins involves the enzymatic synthesis of 2'-5'- oligoadenylates, causing downstream activation of RNase L, leading to RNA degradation and inhibition of protein synthesis. However, the host protective function of multiple enzymatically active and inactive OAS isoforms during bacterial infection is not known. This proposal will address this knowledge gap to define the innate antibacterial functions of two OAS family proteins, OAS1 and OASL. Our preliminary studies suggest that human OAS1 and a mouse ortholog, Oas1b, confer protection from infection with intracellular bacteria by enhancing the expression of several proteins including IRF1, a major antibacterial transcription factor. Furthermore, we found that mice lacking Oasl2 (ortholog of human OASL), another member of OAS family, are highly susceptible to intracellular bacterial infection, and show increased production of host-detrimental inflammatory cytokines. Based on these preliminary findings, we hypothesize that specific members of OAS- family proteins contribute to host defense against intracellular bacteria through unique NTase activity- independent mechanisms. The goal of this proposal is to determine the innate antibacterial functions of two OAS family proteins and the underlying mechanisms in three independent aims: (1) Identify the mechanisms of cell- intrinsic antibacterial activity of OAS1. Here, we will define the molecular mechanism by which OAS1 mediates cell intrinsic antibacterial defense using in vitro biochemical and cell biological approaches. (2) Determine the in vivo role of Oas1b in anti-bacterial innate immunity. We will use a newly generated Oas1b knock-in mouse model to identify the in vivo mediators and cell-type specific antibacterial function of Oas1b. (3) Define the role of OASL in host defense against intracellular bacterial infections and the underlying molecular mechanism(s). Taken together, this proposal is designed to elucidate new NTase activity-independent molecular functions of OAS proteins, and to integrate it with antibacterial cellular defense in an innovative functional-model. Upon completion of this study, we will establish a new paradigm of innate host defense orchestrated by OAS proteins that may lead to new therapeutic strategies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $597,100 )
2026	2026	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Allergy and Infectious Diseases Research	000	4	12/18/2025	NON-COMPETING CONTINUATION	$597,100
														Subtotal = $597,100

Issue Date FY: 2025 ( Subtotal = $616,500 )
2025	2025	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Allergy and Infectious Diseases Research	001	3	12/19/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$616,500
2025	2024	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Allergy and Infectious Diseases Research	000	2	12/19/2024	NON-COMPETING CONTINUATION	$0
2025	2024	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Allergy and Infectious Diseases Research	002	2	4/10/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $616,500

Issue Date FY: 2024 ( Subtotal = $637,370 )
2024	2024	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Allergy and Infectious Diseases Research	000	2	12/4/2023	NON-COMPETING CONTINUATION	$573,633
2024	2024	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Allergy and Infectious Diseases Research	001	2	5/20/2024	NON-COMPETING CONTINUATION	$63,737
														Subtotal = $637,370

Issue Date FY: 2023 ( Subtotal = $686,721 )
2023	2023	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Allergy and Infectious Diseases Research	000	1	1/23/2023	NEW	$686,721
														Subtotal = $686,721

Grand Total All Awards = $2,537,691

Top

All Categories

About

Search

Reports

Data Submission

Award Information

New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections

Award Number: R01AI176333

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/23/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer